.
We also studied the effect of the original 3- or 4-week and extended 12-week dose intervals on infections, hospitalisations, mortality, and public health restrictions.
Early studies show that people also generate a very good immune response measured by cells in their blood when Moderna or Pfizer are used after AstraZeneca.